The University of Surrey has appointed Devereux Architects to create a masterplan for its new School of Veterinary Medicine.
As one of the University's largest and most prestigious future development sites, the new school, which sits within the Faculty of Health and Medical Sciences, will comprise three complimentary and inter-related buildings totalling approximately 9000m2 - an Academic Building, a Veterinary Clinical Skills Centre and a Veterinary Pathology Facility.
The new building will be positioned at the corner of the new campus green at Manor Park. It will feature naturally ventilated office and teaching spaces along one side of the atrium and research spaces and lecture halls along the other. The roof of the atrium is shaped to guide rising, warmed air into the plant room where the heat can be extracted and reused.
The new academic building will provide world-class teaching and research laboratories, lecture theatres, and flexible break out spaces organised around a common shared atrium.
Professor Lisa Roberts, Dean of the Faculty of Health and Medical Sciences, said: "We were very impressed with the design concept for the new School of Veterinary Medicine that Devereux Architects presented at the tendering stage. We are looking forward to working with the professional team at Devereux Architects to deliver this major project for the University of Surrey."
Applications are now open for new members to join the RCVS Preliminary Investigation and Disciplinary Committees.
This is the first time that non-Council members have been able to sit on these two key committees, and follows the approval of a Legislative Reform Order (LRO) to the Veterinary Surgeons Act, which comes into force on 6 April 2013.
Under the new legislation, the two statutory committees will move through a transition period until they completely comprise independently-appointed non-Council members, by July 2015.
This move will provide regulation in line with modern practice, by ensuring that the same group of people is not responsible for setting the rules, investigating complaints and adjudication, and by bringing lay people formally into the Preliminary Investigation Committee.
The LRO will also allow the RCVS to increase the pool of people available to investigate complaints and sit on disciplinary hearings, reducing the workload on the individual Committee members whose primary appointment is to RCVS Council.
This first recruitment phase seeks:
RCVS President, Jacqui Molyneux said: "It's exciting that we can now seek to appoint non-Council members to the two committees involved in our disciplinary system - a breakthrough that has taken a long time to achieve.
"We are interested to hear from veterinary surgeons and lay people who are keen to contribute to the public good and support us in our regulatory role. It's an excellent opportunity to be part of the next chapter of the RCVS, as we become a more modern and effective regulator."
The recruitment process is being handled by Thewlis Graham Associates and details can be found at www.thewlisgraham.com. The selection committee will comprise Sir Michael Buckley, Christopher Laurence MBE QVRM TD BVSc MRCVS and Dr Joan Martin MA FCOT.
The closing deadline for applications is 5pm on Monday 4 March 2013.
Eclipse Veterinary Software has released a new mobile addition to its equine veterinary practice management system.
Eclipse Mobile allows veterinary surgeons to access up-to-date clinical information wherever it is needed, be that on the yard, at the practice, or while making field visits.
When Eclipse Mobile is offline, all the information the vet needs is stored on the device. When next connected via 3G or Wi-Fi, any new details are sent to and from the practice - syncing notes made by the vet, adding follow-on appointments and To Do messages, services delivered and products administered to keep everyone up-to-date throughout the day.
Whilst online, client payments can be taken via debit/ credit cards within the app and detailed drug batch information recorded using the iPad/iPhone's camera as a barcode scanner, if required.
Jeanne Razzell, CEO of Eclipse said: "Many of the vets we work with have been keen to carry animal histories with them on visits, including the latest lab test results, together with recent clinical notes, and diagnostic imaging, e.g. x-rays, ultrasounds and MRI, CT or bone scans. Now, with Eclipse Mobile, every vet can have all of this information at their fingertips automatically - at every appointment; both in the consult room and on the road."
Eclipse Mobile is available for iPad, iPad mini, iPhone, Android smart phones/tablets and Microsoft Windows Surface
For more information, contact Jeanne Razzell, CEO, Eclipse Veterinary Software Limited, on +44 (0)1799 532988 or +44 (0)7515 906466. Website: www.eclipsesoftware.info
A survey carried out by Cats Protection has found that around a quarter of Britain's cats (23%) are being fed treats despite the fact that their owners consider them overweight already.
The survey of 1,120 cat owners revealed that 70% of cats described as 'slightly' or 'very overweight' are given a special food treat at least once a week by their owners. 28% of them are being given a special treat at least once a day.
The survey also found that all cats - irrespective of their weight - are fed special treats over Christmas that are not suitable for their health. Nearly 8% feed their cats a special Christmas dinner consisting of human food, whilst some cats are given chocolate (2%) stuffing (2%), and Christmas pudding (1%).
Maggie Roberts, Cats Protection's Director of Veterinary Services, said: "The survey showed that Britain's overweight cats continue to be fed too many treats, which owners principally did out of love, habit or a desire to make their cat feel like a member of the family. However, overweight cats are at significant risk of diabetes and arthritis so there is the danger that owners are making a bad situation even worse.
"The survey also shows that it wasn't uncommon for cats to be given treats such as milk, chocolate or cheese. All of these could make cats quite ill."
For the research, the medical histories of 188 Basset Hounds and 270 Dachshunds presenting to CVS’ Dovecote Veterinary Hospital and Chestergates Veterinary Specialists, and the University of Ghent were retrospectively assessed.
Information included signalment, whether the dog had received a diagnosis of TL-IVDE, the duration of clinical signs, affected discs and anatomical region and the neurological grading at presentation and discharge.
Basset Hounds and Dachshunds are both chondrodystrophic breeds which are predisposed to IVDE.
However, the study found 77.4% of Dachshunds had presented with IVDE, compared to only 36.2% of Basset Hounds.
Dachshunds also presented earlier (66.5 months) compared to Basset Hounds (median 87.5 months).
Dachshunds had a lower proportion of midlumbar IVDE and were more frequently non-ambulatory at discharge than Basset Hounds.
In addition, Dachshunds were more likely to be paraplegic without sensation at presentation than Basset Hounds (16/154 Dachshunds compared to just one Basset).
The Basset Hound is the largest chondrodystrophic breed and the physical characteristics of this larger body conformation may have benefits, with previous studies suggesting the protective effects of being a larger dog2.
One hypothesis is whether breed conformation and anatomy – the relative height/weight ratio - influences the severity and occurrence of IVD and points to a link between the size of the patient and the space in the vertebral canal.
A smaller spinal cord versus vertebral canal ratio in the Basset Hound may indicate a less compressive lesion.
Sergio Gomes, Head of Neurology and specialist in veterinary neurology at Dovecote Veterinary Hospital, who led the study, said: “This is the first time that IVDE data for Basset Hounds has been directly compared with that for Dachshunds.
“We now need to look closely at the conformation and anatomy of the Basset Hound to see what learnings we can take.
"This could have positive future implications for Dachshund breeding programmes, so that longer term we can try to minimise this painful and common canine condition.”
References
4,661 veterinary surgeons voted, the highest turnout seen in ten years. 1,329 veterinary nurses voted, the highest ever number.
Veterinary surgeons voted incumbents Christopher Gray, Peter Jinman, Bradley Viner, Christopher Tufnell, and Jeremy Davies back onto the RCVS Council. However, the highest number of votes was given to Thomas Witte, who will be new to Council when he takes his seat in July. Veterinary nurses voted similarly by returning Andrea Jeffery to VN Council, whilst giving to Amy Robinson, another newcomer, the largest number of votes.
According to the College, turnout in both elections has increased markedly on last year in both absolute and proportional terms. Votes were cast by 4,661 veterinary surgeons (18.8%) and 1,329 veterinary nurses (12.5%), compared to 3,625 (15.1%) and 743 (7.5%), respectively, in 2012.
Gordon Hockey, RCVS Registrar said: "We're delighted with the increase in turnout. It's difficult to pinpoint the reasons for the increase, but hopefully, it's because increasing numbers of vets and nurses are feeling more engaged with the College. We have also undertaken extra communications activities this year, such as the 'hustings', which we hope have helped."
The Council election 'hustings' was a new venture this year, with RCVS Council candidates able to select three questions, submitted by voters, to answer in a live webinar run by The Webinar Vet.
Veterinary surgeons and VNs could cast their votes by post, online, or by text. The majority of vets voting chose to cast postal votes (3,247), as did the majority of VNs (1,055). Whilst voting online was used by 1,330 veterinary surgeons, only 227 VNs chose it as a means of voting. Voting by text was used by only 84 veterinary surgeons and 47 VNs.
The successful candidates will take up or resume their seats at RCVS Day on 5 July.
The full results of the two elections are as follows:
RCVS Council electionWITTE, Thomas Hermann - 2,251 (Elected)GRAY, Christopher John - 1,974 (Elected)JINMAN, Peter Charles - 1,949 (Elected)VINER, Bradley Phillip - 1,927 (Elected)TUFNELL, Christopher Wynne - 1,883 (Elected)DAVIES, Jeremy Vincent - 1,830 (Elected)STURGESS, Christopher Paul - 1,809 CONNELL, Niall Thomas - 1,596 ROBINSON, Peter Bayley - 1,366 ELLIS, Robert Nigel Ward - 1,302 GRANT, Lewis George - 832 TORGERSON, Paul Robert - 824 LONSDALE, Thomas - 337 Twenty-two votes in the RCVS Council election were found to be invalid.VN Council election
ROBINSON, Amy - 725 (Elected)JEFFERY, Andrea Karen - 607 (Elected)BADGER, Susan Frances - 459TOTTEY, Helen Wendy 332 One vote in the VN Council election was found to be invalid.The 2013 RCVS and VN Council elections were run on behalf of the RCVS by Electoral Reform Services.
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two and four way break tablets facilitate ease of use and should improve compliance. The company also highlights the affordability of the new product, which can be used alone or in conjunction with standard therapies.
According to Alstoe, it is estimated that in 75% of dogs with CHF, degenerative mitral valve disease is the underlying cause. The company says spironolactone shows clear benefits in treating mxyomatous mitral valve disease (MMVD) in dogs: acting as an aldosterone receptor antagonist it counteracts the negative consequences of aldosterone production such as myocardial fibrosis and myocardial and vascular remodelling.
To support the new product, Alstoe has designed a Sleep Respiratory Rate (SRR) chart to assist veterinary professionals with ongoing monitoring of their canine patients condition and response to treatment. The chart is available as a printable download or in pads. The company is also offering lunchtime practice seminars.
Tempora is available as 10mg, 50mg and 100mg tablets.
For further information, contact Alstoe Animal Health on 01347 878606, or via e-mail: adelaideellerington@alstoe.co.uk, or visit www.alstoe.co.uk
Bayer Animal Health, maker of Tracer microchips, has produced a new video in which Emma Milne and Petlog Executive Celia Walsom consider the implications for practices of the change in the law which will make it compulsory for all dogs to be microchipped from April 2016.
The 15-minute video considers various issues, such as:
The College of Animal Welfare has opened a business school at its training and education centre in Chord Business Park in Godmanchester.
CAW Business School provides accountancy courses accredited by the Association of Accounting Technicians (AAT) and leadership and management courses accredited by the Institute of Leadership and Management (ILM).
Leslie Heaton Smith, Director at The College of Animal Welfare, said: "The opening of our Business School is a new development in a long line of achievements and marks an exciting new venture. Whilst our focus has always been towards developing technical animal and veterinary related knowledge and skills to make significant improvements in animal welfare and veterinary care, we also recognise that quality of care is also highly dependent on the management and leadership of those controlling and investing the organisation's often scarce resources. Thus in order to provide high quality welfare to animals entrusted into their care, organisations need to be able to employ people with such skills".
The leadership and management courses are already underway and can be studied entirely online, or online with study weekends.
The College says the majority of AAT courses will start in September 2013, however an 8 week Level 2 Certificate in Bookkeeping course starts at the beginning of June. The College is also an AAT approved exam centre, meaning that students can sit their exams whilst at college.
For further information, call the College on 01480 422060 and speak to one of the Business School tutors. Alternatively, visit www.caw.ac.uk or book a place on the next open day on Wednesday 22 May from 9am-12pm or 6-9pm.
The American Kennel Club Canine Health Foundation has awarded Dr. Bruce Smith, director of the Auburn University Research Initiative in Cancer, a two-year grant totaling $118,848 to test a new therapy for treating bone cancer in dogs.
According to the University, the research could one day be broadened to include many other kinds of cancer - and possibly cancer in people.
The treatment consists of a virus normally used as a hepatitis vaccine in dogs that has been modified to only make copies of itself inside bone cancer cells. The virus ruptures the cancer cells, releasing thousands of copies of the virus from the tumor cells, killing them.
Dr. Smith said: "By using this approach, we turn the cancer cell into a 'factory' that produces more virus. You could say that we help the cancer cell become an agent of its own death."
Bone cancer, or osteosarcoma, accounts for around 5% of tumours in dogs. More than 90% of dogs with this tumour have had tumour cells migrate into their lungs, creating what are known as micrometastases, at the time of diagnosis.
Dr. Smith said: "This therapy attacks those metastases and will hopefully eliminate them or make them more sensitive to chemotherapy."
The Auburn University Research Initiative in Cancer, or AURIC, was founded in 2012 to accelerate translation of cancer innovation from the laboratory to the clinic. AURIC embodies "One Medicine" - the concept that sees human and animal health as a single field where discoveries in one species advance health in both species.
Fitzpatrick Referrals has launched a new sports medicine and rehabilitation centre for dogs at its referral centre in Surrey.
Fitzpatrick Referrals has been running a dedicated rehabilitation centre since the practice opened at Eashing in 2007. It has now extended the offering to include sports medicine clinics and osteoarthritis clinics, creating what it claims is the largest centre of its kind in the country.
Building work has now been completed at the centre and Fitzpatrick Referrals has appointed David Prydie MRCVS, a small animal rehabilitation expert, to head up the centre.
Speaking about the launch of the new service, Noel Fitzpatrick, Managing Director of Fitzpatrick Referrals said: "At Fitzpatrick Referrals, we believe that appropriate rehabilitation is integral to the success of orthopaedic and neuro-surgical intervention and fundamental in promoting pain free functional quality of life.
"Traditionally, the rehabilitation centre has been geared towards treating post-op patients. While the new centre will continue to treat animals which have been referred to Fitzpatrick Referrals for surgical procedures, helping to restore function, reduce pain and speed up the recovery process, we will now offer new dedicated Sports Medicine and Osteoarthritis clinics, of which there are currently only a handful in the UK. This will provide referring practitioners and clients with a new range of options for dealing with sports injuries and the on-going management of Osteoarthritis.
"For the first time, minimally invasive arthroscopic investigation and advanced diagnostic imaging with MRI and CT will be available side-by-side with a team of clinicians who truly understand the unique anatomy, physiology and exercise demands of working and sports dogs and who adopt an integrated approach to achieving maximum mobility for dogs of all ages. We intend that the new centre will create a new standard of integrated care for the active performance or pet dog because we will match function with form and intention with action. Every plan will be tailor made for the individual with sincere attention to the very special environment and demands of the sporting dog. I'm extraordinarily excited about this new horizon."
David Prydie added: "We expect to see cases where there are specific injuries which the canine athlete is prone to and which require specialist knowledge to identify and treat. Our goal is to help the dogs return to their performance event as soon as possible. We will also be offering advice on training regimes for the various activities. The centre will offer a new osteoarthritis clinic, treating osteoarthritis in all ages of dog using a multimodal approach such as weight management, exercise regimes, physiotherapy techniques and use of tools such as the therapeutic laser. There is a wealth of experience already present within the practice and I will be working with Noel and the other surgeons to develop our offering in sports injury management and also with Professor Stuart Carmichael in the development of osteoarthritis management schemes."
The practice will celebrate the launch of the new centre with its first festival for pets, 'Dogfest', built around the theme of the 'Active Dog'. The festival will take place on 10th and 11th of August and will feature a number of agility and flyball events, canine sports medicine lectures delivered by world experts, a range of tents and stalls, 'Have a Go' agility sessions, an agility display by former Fitzpatrick patients who have returned to compete in the agility circuit, a 'Meet the Fitzpatrick Heroes' display and a special '999' display by the Sussex Police Dogs on both days.
For information on the new Fitzpatrick Sports Medicine and Rehabilitation Centre services and to discuss referrals, contact the reception team on 01483 423 761.
Each candidate will produce a written reply to two questions of their choice, which will be included on their candidate profile webpage ahead of the start of the election.
The three candidates who are standing in this year’s election for the two available elected places on VN Council are:
The VN Council candidate biography and statements are available to read on www.rcvs.org.uk/vnvote24
The two candidates with the most votes will join VN Council for their three-year terms at the College’s AGM in July.
The College says it will only accept one question per person and questions must be decent.
Offensive, defamatory and inaccurate questions will not be passed on to candidates.
You can email your question to: vnvote24@rcvs.org.uk.
Virbac is offering its customers a discount on subscriptions to Vet Care Consult, an interactive veterinary medicine and anatomy tool designed to improve client understanding and aid compliance.
Vet Care Consult, designed by MediProductions with advice from veterinary specialists, uses more than 600 3D graphics, animations, videos and other imagery to help veterinary staff explain diagnoses and to discuss therapeutic options.
The veterinary surgeon or nurse selects the target species, then the relevant organ or system. A range of animations and videos are then offered to help explain their recommendation. The tool includes the option to email owners a link to a specific animation or video so that they can discuss the recommended treatment with family later. It can be used on a PC or tablet and is also available as an iPhone app.
A single user subscription normally costs £41 per month or £410 per annum.
Chris Geddes MRCVS, Senior Product Manager at Virbac, said: "Gone are the days of scribbling diagrams on scraps of paper and whiteboards or pointing to a model of a stifle that has seen better days!
"Vet Care Consult harnesses the latest technology to help the veterinary team communicate more effectively with clients, helping them to understand their pets' health and wellness issues. Better communication leads to improved compliance which, in turn, helps to strengthen the vital bond between a practice and its clients."
For more information, contact your Virbac Territory Manager.
The app allows practices to submit results along with cytology and histopathology results in order to help train the AI algorithm and improve its accuracy from an original sensitivity of 85% and negative predictive value of 97%.
Liron Levy-Hirsch, Managing Director of HT Vista, said: “The HT app has provided us with over 700 additional validated scans to analyse this year alone.
"The validation process is well controlled, whereby we use the lab results to tag the scans as benign or malignant and let the algorithm know if it was correct or not.
"The more we train the algorithm the more accurate it becomes, and it is extremely exciting to see the sensitivity increase to 90% and the NPV to 98%.”
HT Vista says the app was developed to meet demand from clinics.
Liron said: "By having a portal to upload lab results alongside the device’s results not only do we further improve the device, but we also increase confidence among our vets and nurses that the device is a reliable tool.
https://ht-vista.uk
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
The WSAVA's Global Nutrition Committee (GNC) has launched a Nutrition Toolkit for veterinary professionals.
The non-branded toolkit contains the following materials:
The toolkit is available for download at http://wsava.org/nutrition-toolkit.
Based on its importance to overall health, the WSAVA is campaigning to have a nutritional assessment confirmed as the fifth vital assessment in a standard physical examination and for the veterinary healthcare team to provide nutritional recommendations for each animal as an integral component of patient care.
The launch of the Nutrition Toolkit follows on from the Global Nutrition Committee's first initiative, the creation of a set of Nutrition Guidelines in 2011. These were aimed at helping veterinary professionals and pet owners ensure that pets are fed according to an optimal and individually tailored nutrition plan. According to WSAVA, they have been successful, securing endorsements from 19 veterinary organizations in 16 countries. They have been translated into ten languages and are available for download at http://www.wsava.org/guidelines/global-nutrition-guidelines.
GNC Co-Chair Dr Marge Chandler said: "Research shows that more than 90% of pet owners would like nutritional advice but fewer than 15% feel they receive it. In some parts of the world, pet malnutrition remains a major challenge, while in many other countries, pet obesity is an increasing problem. In addition, there is confusion about optimal nutrition because there is now so much conflicting and inaccurate information available online.
Our Nutrition Toolkit is designed to help the veterinary healthcare team address nutrition at every patient visit and to advance the central role of the veterinary healthcare team as the expert source of nutrition information."
Owners of hyperthyroid cats say they would rather veterinary surgeons prescribed the appropriate dosage for their pets than have an easy way to administer the medicine, according to new research carried out by feline expert Dr Sarah Caney BVSc PhD DSAM (Feline) MRCVS.
111 cat owners were questioned for the research, which was supported by Dechra Veterinary Products and has been accepted for publication in the Journal of Feline Medicine and Surgery.
Dechra says the results of the study challenge long-held perceptions, and should encourage a reappraisal of the approach to oral anti-thyroid medication:
89% of cat owners agreed with the statement that it 'was more important to me that the vet prescribes the most appropriate dose for my cat than that they provide me with an easy method of administering the medicine.'
Dr Caney said: "The survey has shown that cat owners are not a barrier to prescribing twice daily medication. Their overwhelming drive is to provide the best level of care that they can.
"From an owner perspective, the ideal anti-thyroid medication offers low doses and a variety of dosing strategies to ensure that each individual cat receives the dose they need and no more."
The findings revealed that 'once daily treatment' was not ranked as the most important statement on dosing by any of the owners and that only 21% of owners who had experienced oral dosing of their cat described the process as either 'tricky' or 'very difficult'.
Craig Sankey, Brand Manager for Felimazole at Dechra Veterinary Products, said: "We are very pleased to have supported such an important piece of independent research relating to feline hyperthyroidism which challenges some of the assumptions made about owner needs.
"Ease of administering the medicine is not the overwhelming issue for owners of cats with hyperthyroidism - administering the correct dose is. In fact, 79 % of cat owners questioned were happy to give pills twice a day if necessary."
To see the latest research in full, please visit www.dechra.co.uk/hyperthyroidism
The Client Care Hub, which is thought to be an industry-first, aims to provide CVS's 1,100 receptionists – and other colleagues who look after clients in CVS’ practices, crematoria and laboratories – with a solid foundation in all aspects of good client care.
The training hub offers a range of live and on-demand courses, including short courses, guides, webinars, in-depth courses and a Level 4 certificate programme.
Courses cover various aspects of client care, such as handling challenging conversations, triaging cases, diary management, finance, and personal wellbeing.
Some course content, designed by CVS’ in-house team in collaboration with receptionists and practice managers, is unique to the veterinary profession.
Philip Webb, Learning Partner at CVS Group, said: "We hope the quality of training we’re offering, along with the peer support network we’re facilitating, will make our colleagues’ day-to-day life even more rewarding and will longer-term serve to develop their careers.”
https://knowledgehub.cvsukltd.co.uk
Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy.
Canine epilepsy can affect up to 5% of dogs6. In most dogs diagnosed with idiopathic epilepsy no underlying cause for the seizures can be found. While the condition can affect any dog, it is more common in young (one to five year old), purebred dogs such as Labradors, Golden Retrievers, German Shepherds, Boxers, Vizlas, Beagles, English Springer Spaniels, Irish Setters, Poodles and Dachshunds.
Boehringer says Pexion has a highly targeted mode of action1-3 to suppress a dog's seizures. It starts to work within a few hours and reaches steady state within three days4,5. Boehringer claims this will make it easier to stabilise epileptic patients. It also says there is no evidence of hepatotoxicity or liver-associated enzyme elevation, so repeated blood tests for liver enzymes or therapeutic levels are no longer required.4,5
Pexion is available in 100 mg and 400 mg tablets. The tablets are white, scored and divisible in half. Both tablet strengths are available in 100 tablet packs from veterinary wholesalers.
Jemima Mead, brand manager at Boehringer said: "Pexion is a ground-breaking new product which gives vets a new first-line treatment option for dogs with idiopathic epilepsy, improving the lives of newly diagnosed epileptic dogs and their owners by reducing the number of seizures and their impact on the patient's life".
To support the launch of the new product, Boehringer hosted an epilepsy webinar presented by neurologist Dr Holger Volk DVM PhD DipECVN FHEA MRCVS, recognised RCVS and European Specialist in Veterinary Neurology. The webinar is now available on demand at www.bi-academy.co.uk.
For further information on Pexion visit www.pexion.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
Invicta Animal Health has launched EthyCalm Spray, a cryoanalgesic for minor procedures.
The active ingredient, ethyl chloride, acts as a local analgesic (pain relief) when sprayed or wiped onto the skin.
According to the company, the product is effective in a few seconds and works for a few minutes until the skin warms up again. This makes it suitable for such things as venepuncture, tick removal or placing of PVC's, where it should help reduce stress for the patient and the practitioner.
Ethycalm is presented in a 50ml vial which provides up to 100 applications.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to launch EthyCalm. During theatre training sessions for our product, ChloraPrep, we realised that the busy nurse doesn't have time to use traditional analgesia methods such as creams. They needed something instant yet cost-effective. Seeing the widespread use of ethyl chloride in places like Great Ormond Street Hospital, it was obvious that this product needed to be made available to veterinary practices".
For further information see www.invictavet.com or phone 01403 791313
Bayer Animal Health has announced the launch of a new campaign which plays on our anthropomorphic nature to drive owners into practice for worming.
As part of the campaign, the company has enrolled the behaviour specialist and author Sarah Whitehead to oversee a video analysis of the behavioural interaction between a small number of dogs and their owners. The results will be used to make an educational film for pet owners which helps them better understand their pet's emotions and behaviour.
Tracey Dawson, Group Product Manager at Bayer Animal Health said: "We want owners to really understand the importance of health on their dog's happiness and behaviour, whilst reminding them to worm their pet at least four times a year. Our ground breaking research will make owners feel like real-life Dr Doolittle, as they will better understand their pet's emotions and actions, highlighting the importance of keeping their dogs healthy, happy and worm-free."
In order to prompt owners to worm their dog more frequently, Bayer has also launched a free SMS/email worming reminder service available at www.drontal.com. In addition, there'll be a new CPD section for SQPs on the website in the summer..
Bayer is also developing 'Worm Reminder' toolkits for veterinary practices, including a press release template, infographics, and video report of the research findings to further promote the importance of worming frequently. For more information, talk to your Bayer representative.
Dechra Veterinary Products has relaunched Oxyglobin after concluding an exclusive agreement to supply the product across the UK and Republic of Ireland.
Oxyglobin is used to stabilise anaemic dogs until the underlying condition can be controlled and the animal's body can produce its own new red blood cells.
Dechra says the treatment, which is now available in both 125ml bags and individual 60ml transfusion bags, maintains tissue oxygenation even when there is severe stenosis of blood vessels. It has a viscosity which is more than water but less than blood for ease of flow through vessels, and also increases circulatory volume.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Veterinary professionals have been waiting for Oxyglobin to come back onto the market for some time and we're delighted to be able to relaunch it in the UK and Republic of Ireland.
"It was withdrawn from the market in 2010 when OPK Biotech acquired the assets of manufacturer Biopure Corporation in 2009. But this year, OPK Biotech resumed the manufacture of Oxyglobin and we have stocks available to practices from this month (FEB)."
"Oxyglobin turns around clinical outcomes for dogs with anaemia, regardless of the cause of the condition, which is why it is the objective choice for safety, effectiveness and convenience.
"Oxyglobin is the only oxygen-carrying fluid available off the shelf for dogs in need of oxygen support and no typing or cross-matching of the recipient's blood is required."
Oxyglobin, a sterile formulation of polymerised purified bovine haemoglobin in a balanced salt solution with proven efficacy, is available in single dose 60ml and 125ml infusion bags.
For further information on Oxyglobin, see www.dechra.co.uk
The company says the new addition leverages a combination of image recognition technology, algorithms, and cloud-based deep learning AI to enable accurate, in-clinic sediment analysis of fresh urine, delivering results within minutes.
The system evaluates red and white blood cells, squamous and other epithelial cells (e.g. urothelial and renal tubular epithelial cells), hyaline and non-hyaline casts, struvite and calcium oxalate dihydrate crystals, and cocci and rod bacteria.
Zoetis says its performance is comparable to that of a clinical pathologist.
Richard Goldstein, DVM, DACVIM, DECVIM-CA, Vice President and Chief Medical Officer, Global Diagnostics Medical Affairs at Zoetis said: “Urinalysis is an essential diagnostic test for veterinary surgeons, and often a good indicator of potential wider issues.
"Having the ability to get these results faster will improve the speed and level of care teams can provide their patients, facilitating efficient medical decision-making and helping to ensure smooth workflows.
Jon Bowen, animal behaviour consultant at the Royal Veterinary College and Sureflap have declared 8th May 'Vet Cat Watch Day', and are asking the profession to record the reason why each cat seen that day is brought into the practice.
Jon explained: "There are more than 10 million pet cats in the UK, however there is little information about the prevalence of injuries, disease, cat fights and road traffic accidents on a national scale".
The absence of data became apparent when findings from research on over 1,000 cats - conducted as part of the Neighbourhood Cat Campaign, supported by SureFlap and Your Cat magazine - revealed cats that had suffered minor injuries from fights were more likely to develop other health issues, such as hair loss and eye infections.
Judith Bank from SureFlap said: "People often purchase a microchip-operated cat flap to help their pet to feel secure. Owners tell us that their pet is spraying in the house or has been losing fur and this motivated us to support research to look deeper into the problems that pet owners might be having. We soon realised that objective data from vets was not available to qualify the findings and this is where the idea of 'Vet Cat Watch Day' emerged."
Jon said: "The aim of Vet Cat Watch Day is to take a snap-shot of cats' health from veterinary practices across the nation, on one day. The results will be compiled alongside information from cat owners gained in 'Cat Watch Day' a few days earlier.
A report detailing preliminary findings from the Neighbourhood Cat Campaign is available from the SureFlap website. When complete the results will be used to help provide vets with an insight into the lives of domestic cats so they are better equipped to understand behavioural issues.
For more information on Vet Cat Watch Day please visit the SureFlap website The site hosts a PDF to print out and help record the feline cases that come through practice doors on the 8th May, which can be downloaded from www.sureflap.co.uk/vetwatch_info. At the end of the day, visit www.sureflap.co.uk/vetwatch to upload your data to the online survey.